Cargando…

Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies

BACKGROUND: Janus kinase (JAK)‐mediated cytokine signalling contributes to local and systemic inflammation in hidradenitis suppurativa (HS). OBJECTIVES: To describe the safety and efficacy results from two multicentre phase II trials of the JAK1 inhibitor INCB054707 in patients with moderate‐to‐seve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alavi, Afsaneh, Hamzavi, Iltefat, Brown, Kurt, Santos, Leandro L., Zhu, Zhaoyin, Liu, Huiqing, Howell, Michael D., Kirby, Joslyn S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314604/ https://www.ncbi.nlm.nih.gov/pubmed/34978076 http://dx.doi.org/10.1111/bjd.20969

Ejemplares similares

Update on hidradenitis suppurativa: connecting the tracts
por: Gill, Liza, et al.
Publicado: (2014)

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
por: Garg, Amit, et al.
Publicado: (2022)

Hidradenitis suppurativa: an update on connecting the tracts
por: Smith, Mallory K, et al.
Publicado: (2017)

The most recent advances in understanding and managing hidradenitis suppurativa
por: Narla, Shanthi, et al.
Publicado: (2020)

Ertapenem rescue therapy in hidradenitis suppurativa
por: Chahine, Adam A., et al.
Publicado: (2018)

Evaluating the Impact of Exclusion Criteria on the Generalizability of Hidradenitis Suppurativa Treatment Research
por: Maghfour, Jalal, et al.
Publicado: (2023)

Systematic review of photodynamic therapy for the treatment of hidradenitis suppurativa
por: Reshetylo, Sofiya, et al.
Publicado: (2022)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Provider perspectives on the management of hidradenitis suppurativa in pregnancy – A survey study
por: Collier, Erin K., et al.
Publicado: (2020)

Evaluating the hidradenitis odor and drainage scale (HODS): A new validated potential instrument to assess odor and drainage in hidradenitis suppurativa—A cross-sectional study
por: Alavi, Afsaneh, et al.
Publicado: (2022)

Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: The SHARPS Randomized Clinical Trial
por: Bechara, Falk G., et al.
Publicado: (2021)

COVID-19 Infection in Hidradenitis Suppurativa Patients: A Retrospective Study
por: De, Devea R., et al.
Publicado: (2023)

Modulation of Disease-Associated Pathways in Hidradenitis Suppurativa by the Janus Kinase 1 Inhibitor Povorcitinib: Transcriptomic and Proteomic Analyses of Two Phase 2 Studies
por: Liu, Huiqing, et al.
Publicado: (2023)

Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts
por: Rick, Jonathan W., et al.
Publicado: (2022)

T-cell/histiocyte-rich large B-cell lymphoma in a 27-year-old with hidradenitis suppurativa, psoriasis, and vitiligo: Implications for screening
por: Vellaichamy, Gautham, et al.
Publicado: (2020)

Association of hidradenitis suppurativa and keloid formation: A therapeutic challenge
por: Jfri, Abdulhadi, et al.
Publicado: (2019)

Validation of the Hidradenitis Suppurativa Investigator Global Assessment: A Novel Hidradenitis Suppurativa–Specific Investigator Global Assessment for Use in Interventional Trials
por: Garg, Amit, et al.
Publicado: (2023)

A survey of dermatologist perspectives on disease management of patients with hidradenitis suppurativa
por: Shi, Vivian Y., et al.
Publicado: (2022)

Patient perspectives on diagnosis and management of hidradenitis suppurativa: A web-based survey
por: Hsiao, Jennifer L., et al.
Publicado: (2022)

Rapid healing of chronic ulcerations and improvement in range of motion after fractional carbon dioxide (CO(2)) treatment after CO(2) excision of hidradenitis suppurativa axillary lesions: A case report
por: Nicholson, Cynthia L., et al.
Publicado: (2016)

Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review
por: Sachdeva, Muskaan, et al.
Publicado: (2021)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

Hidradenitis suppurativa and vasculitis: A case series and literature review of a rare association
por: Alavi, Afsaneh, et al.
Publicado: (2019)

Association of myalgias with compounded topical Janus kinase inhibitor use in vitiligo
por: Narla, Shanthi, et al.
Publicado: (2020)

Work impairment in a woman with severe hidradenitis suppurativa after delayed diagnosis: A call for action
por: Shah, Monica, et al.
Publicado: (2020)

Recent advances in hidradenitis suppurativa: Role of race, genetics, and immunology
por: Vellaichamy, Gautham, et al.
Publicado: (2022)

Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study
por: Masson, Rahul, et al.
Publicado: (2023)

Retrospective cohort study of pregnancy outcomes in hidradenitis suppurativa
por: Lyon, A.B., et al.
Publicado: (2020)

Dysregulated CD38 expression in blood and skin immune cells of patients with hidradenitis suppurativa
por: Mi, Qing-Sheng, et al.
Publicado: (2023)

Hidradenitis Suppurativa Quality of Life (HiSQOL): creation and validation of the Polish language version
por: Krajewski, Piotr K., et al.
Publicado: (2020)

Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes
por: Thorlacius, Linnea, et al.
Publicado: (2017)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Characteristics and treatment pathways in pediatric and adult hidradenitis suppurativa: An examination using real world data
por: Hardin, Jill, et al.
Publicado: (2023)

Quality of life and sexual health in patients with hidradenitis suppurativa()()
por: Alavi, A., et al.
Publicado: (2018)

Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
por: Fotiadou, Christina, et al.
Publicado: (2016)

A Case of Moderate Hidradenitis Suppurativa and Psoriasis Treated with Secukinumab
por: Giuseppe, Pistone, et al.
Publicado: (2018)

Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature
por: Hoffman, Lauren K., et al.
Publicado: (2018)

The prevalence of hidradenitis suppurativa outside the hospital setting: the impact of the undiagnosed
por: Kearney, Niamh, et al.
Publicado: (2022)

Surgical Management of Hidradenitis Suppurativa
por: Menderes, Adnan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_58eth2icfjns47pv1pk9llqnhm